Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insmed (INSM) Retained Earnings (2016 - 2026)

Insmed's Retained Earnings history spans 17 years, with the latest figure at -$5.8 billion for Q1 2026.

  • Quarterly Retained Earnings fell 25.64% to -$5.8 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$5.8 billion through Mar 2026, down 25.64% year-over-year, with the annual reading at $1.5 million for FY2025, 163.83% up from the prior year.
  • Retained Earnings came in at -$5.8 billion for Q1 2026, down from $1.5 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of $1.7 million in Q2 2025 to a low of -$5.8 billion in Q1 2026.
  • The 5-year median for Retained Earnings is -$2.5 billion (2022), against an average of -$2.0 billion.
  • Year-over-year, Retained Earnings tumbled 2536555.0% in 2022 and then skyrocketed 163.83% in 2025.
  • Insmed's Retained Earnings stood at -$2.7 billion in 2022, then dropped by 27.8% to -$3.4 billion in 2023, then skyrocketed by 99.93% to -$2.3 million in 2024, then surged by 163.83% to $1.5 million in 2025, then plummeted by 397105.82% to -$5.8 billion in 2026.
  • Per Business Quant, the three most recent readings for INSM's Retained Earnings are -$5.8 billion (Q1 2026), $1.5 million (Q4 2025), and -$5.3 billion (Q3 2025).